Recording intelligenceAI-generated brief · check the source for context

Pre-Bunking Misinformation

45:17 recording · AUTO · 2 speakers

Listen to the original

Listen to the episode
Executive Summary AI
  • Daniel Griffin opens with Kristen Panth's piece "Five Logical Fallacies in the Era of RFK Jr." and its case for pre-bunking — teaching people to recognise rhetorical tricks instead of chasing each claim, backed by seven pre-registered inoculation studies with nearly 30,000 participants in Science Advances.4:00
  • The STOMP trial in the New England Journal of Medicine, with Jason Zucker of Columbia University as first author, found tecovirimat no better than placebo for MPOX — 83% versus 84% clinical resolution by day 29 among 412 randomised participants — which Daniel says takes the drug off the table and leaves no effective treatment.10:28
  • A MedArchive preprint put the 2025 cost per measles case at $104,629 and the national burden at $244 million, with declining MMR coverage projected to cost $7.77 billion over five years.13:07
  • Case counts keep climbing — 990 confirmed in South Carolina as of March 3rd, 358 in Utah, and at least 14 active cases at the Camp East Montana ICE facility near El Paso — while the expert meeting on U.S. measles elimination status has been pushed to November.19:51
  • On the respiratory viruses, flu sits on a plateau with 79 pediatric deaths this season and the WHO recommending all three strains be changed, while a South Korean randomized trial found neither metformin nor ursodeoxycholic acid treated long COVID (recovery 63.6% on metformin versus 68% on placebo).30:36

Brief overview

Daniel Griffin's clinical update: tecovirimat fails for MPOX, measles surges past 1,000 cases, vaccine policy ignores data.

  1. Tecovirimat is off the table for MPOXThe STOMP trial showed 83% resolution on drug versus 84% on placebo, with no difference in pain, healing or viral clearance.
  2. Measles is now a billion-dollar problemAt $104,629 per case and a projected 6,000-7,000 cases this year, declining MMR coverage is modelled at $7.77 billion over five years.
  3. Pre-bunk the fallacy, don't chase every rumourDaniel likens teaching the five logical fallacies to vaccinating before exposure rather than treating each misinformation infection.

Questions this recording answers

10 questions, each answered where it is said
Does tecovirimat work for treating mpox?

No. The STOMP phase three trial, published in the New England Journal of Medicine with Jason Zucker as first author, randomized 412 participants two-to-one. By day 29 clinical resolution was 83% with tecovirimat versus 84% with placebo, with no substantial difference in pain reduction, lesion healing or viral DNA clearance.

Answered around 10:28
How many measles cases has the United States had this year?

Over a thousand confirmed cases in the first two months of the year, putting the country on track for more than 6,000. The Johns Hopkins tracker, which runs behind, is almost at 1,200. South Carolina alone had 990 confirmed cases as of March 3rd, and Utah is up to 358.

Answered around 12:39
What does a measles case cost the healthcare system?

A MedArchive preprint estimated the 2025 cost per measles case at $104,629, a national burden of $244 million. At roughly 6,000 cases the total approaches a billion dollars. Costs were highest in Arizona, California and Texas, lowest in Maine, with a cumulative $7.77 billion over five years.

Answered around 13:07
What are the risks of measles for an unvaccinated child?

Infected unvaccinated children are 2.7 times more likely to be hospitalized and three times more likely to get a prescription anti-infective, with risk 22% higher for the rest of the year. Measles also brings ear infections, diarrhea, 20% hospitalization, 5% pneumonia, one in a thousand brain swelling.

Answered around 16:57
Do metformin or ursodeoxycholic acid treat long COVID?

No. In a double-blind randomized trial at two tertiary hospitals in South Korea, 396 adults with a PASC score of 12 or greater got metformin up to 1500 mg daily, UDCA 900 mg daily, or placebo for 14 days. Recovery was 63.6%, 68% and 68% respectively.

Answered around 32:04
Should adults born in the 1980s get a second MMR dose?

Yes. Measles is back, so anyone who is an 80s kid and received only the single MMR dose is advised to go ahead and get that second shot. The second dose provides a little more protection and seems to help substantially at a population level as well.

Answered around 40:43
What is pre-bunking and does it actually work against misinformation?

Pre-bunking teaches people to recognize falsehoods before they encounter them, instead of exhausting whack-a-mole on individual claims. The Science Advances article Psychological Inoculation Improves Resilience Against Misinformation on Social Media covered seven high-powered pre-registered studies, including a YouTube field experiment, with nearly 30,000 participants total.

Answered around 4:22
What flu strains did the WHO recommend for next season's vaccines?

The WHO recommended completely changing all three viral strains for the northern hemisphere's next season, including the new H3N2 subclade K variant that rose last fall. Egg-based vaccines carry an influenza B Tokyo, cell culture, recombinant protein and nucleic acid vaccines an influenza B Pennsylvania, both Victoria lineage.

Answered around 23:35
Has H5N1 bird flu reached marine mammals in California?

Yes. UC Davis confirmed highly pathogenic avian influenza in seven northern elephant seals, the first H5N1 detection in marine animals in California. The seals lived at the Ano Nuevo reserve near Santa Cruz, a park home to 5,000 seals in winter; 1,350 were on the beach when the outbreak began.

Answered around 11:32
Is there a booster recommendation for the RSV vaccine?

Not yet. Boosters and their possible benefits have been looked at, but there is still no booster recommendation for RSV vaccination. It was not clear that a second shot would give any real advantage at this point. After one shot, wait until more is known.

Answered around 34:14
Key Quote

“Yeah, no, I think this just takes tecovirumab off the table.”

— Daniel Griffin, Pre-Bunking Misinformation, at 10:55▶ listen at 10:55
Key Quote

“So, yeah, I think, you know, it's unfortunate because now we have no treatment, no effective treatment for MPOX.”

— Daniel Griffin, Pre-Bunking Misinformation, at 11:08▶ listen at 11:08
Key Quote

“So this scenario would result in a cumulative cost of $7.77 billion over five years.”

— Daniel Griffin, Pre-Bunking Misinformation, at 13:51▶ listen at 13:51
Key Quote

“It's quite clear we lost the status.”

— Daniel Griffin, Pre-Bunking Misinformation, at 16:14▶ listen at 16:14
Key Quote

“So it's coming from an ideological stance.”

— Daniel Griffin, Pre-Bunking Misinformation, at 29:13▶ listen at 29:13
Key Quote

“I mean, we had over a thousand children die in the U.S. from COVID.”

— Daniel Griffin, Pre-Bunking Misinformation, at 39:28▶ listen at 39:28

Cite this

“Pre-Bunking Misinformation.” https://traffic.libsyn.com/secure/twiv/TWiV1302.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/pre-bunking-misinformation.html.

Report this page
What is wrong with this page?